Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat

Journal of Vascular Research

Volumn 46, Issue 4, 2009, Pages 311-324

  Testa, Jacqueline E ^a   Chrastina, Adrian ^a   Li, Yan ^a   Oh, Phil ^a   Schnitzer, Jan E ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

Biodistribution; Caveolae; Immunofluorescence; Immunohistochemistry; Molecular imaging; SPECT imaging

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY G278; PODOCALYXIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; SIALOGLYCOPROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BREAST TUMOR; CANCER TISSUE; CAVEOLA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RAT; SARCOMA CELL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE SECTION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BRAIN; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY BLOOD VESSEL; FISCHER 344 RAT; IMMUNOLOGY; KIDNEY; LIVER; LUNG; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; TUMOR CELL LINE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRAIN; CAVEOLAE; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; SIALOGLYCOPROTEINS; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149360475     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189792     Document Type: Article

References (42)

1. Schnitzer JE: Update on the cellular and molecular basis of capillary permeability. Trends Cardiovasc Med 1993;3:124-130.
2. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 2005;438:932-936.
3. Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, Testa JE, Oh P, Schnitzer JE: Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol 2004;22:985-992.
4. McIntosh DP, Tan XY, Oh P, Schnitzer JE: Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci USA 2002;99:1996-2001.
5. Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, Testa JE, Schnitzer JE: Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004;429:629-635.
6. Valadon P, Garnett JD, Testa JE, Bauerle M, Oh P, Schnitzer JE: Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci USA 2006;103:407-412.
7. Oh P, Schnitzer JE: Immunoisolation and subfractionation of plasma membranes to purify caveolae separately from glycosylphosphatidylinositol- anchored protein microdomains; in Celis J (ed): Cell Biology: A Laboratory Handbook. New York, Academic Press, 1998, pp 34-46.
8. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P: Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 1995;269:1435-1439.
9. Rizzo V, Morton C, DePaola N, Schnitzer JE, Davies PF: Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J Physiol Heart Circ Physiol 2003; 285:H1720-H1729.
10. Schnitzer JE, Liu J, Oh P: Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem 1995;270:14399-14404.
11. Schnitzer JE, Oh P: Aquaporin-1 in plasma membrane and caveolae provides mercurysensitive water channels across lung endothelium. Am J Physiol 1996; 270:H416-H422.
12. Harlow E, Lane D: Antibodies: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1988.
13. Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol 2007;25:327-337.
14. Miettinen A, Solin ML, Reivinen J, Juvonen E, Vaisanen R, Holthofer H: Podocalyxin in rat platelets and megakaryocytes. Am J Pathol 1999;154:813-822.
15. Oh P, McIntosh DP, Schnitzer JE: Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 1998;141:101-114.
16. Schnitzer JE, Oh P, McIntosh DP: Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 1996;274:239-242.
17. Russell J, O'Donoghue JA, Finn R, Koziorowski J, Ruan S, Humm JL, Ling CC: Iodination of annexin v for imaging apoptosis. J Nucl Med 2002;43:671-677.
18. Kraemer M, Tournaire R, Dejong V, Montreau N, Briane D, Derbin C, Binetruy B: Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors. Cell Growth Differ 1999;10:193-200.
19. Furness SG, McNagny K: Beyond mere markers: Functions for CD34 family of sialomucins in hematopoiesis. Immunol Res 2006;34:13-32.
20. Kerjaschki D, Sharkey DJ, Farquhar MG: Identification and characterization of podocalyxin - the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 1984;98:1591-1596.
21. Horvat R, Hovorka A, Dekan G, Poczewski H, Kerjaschki D: Endothelial cell membranes contain podocalyxin - the major sialoprotein of visceral glomerular epithelial cells. J Cell Biol 1986;102:484-491.
22. Miettinen A, Dekan G, Farquhar MG: Monoclonal antibodies against membrane proteins of the rat glomerulus. Immunochemical specificity and immunofluorescence distribution of the antigens. Am J Pathol 1990;137:929-944.
23. Lin WL, Pang VF, Liu CH, Chen JY, Shen KF, Lin YY, Yu CY, Hsu YH, Jou TS: Pleomorphic extra-renal manifestation of the glomerular podocyte marker podocalyxin in tissues of normal beagle dogs. Histochem Cell Biol 2007;127:399-414.
24. Dekan G, Miettinen A, Schnabel E, Farquhar MG: Binding of monoclonal antibodies to glomerular endothelium, slit membranes, and epithelium after in vivo injection. Localization of antigens and bound IGGs by immunoelectron microscopy. Am J Pathol 1990;137:913-927.
25. Ney JT, Zhou H, Sipos B, Buttner R, Chen X, Kloppel G, Gutgemann I: Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts. Hum Pathol 2007;38:359-364.
26. Doyonnas R, Nielsen JS, Chelliah S, Drew E, Hara T, Miyajima A, McNagny KM: Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood 2005;105:4170-4178.
27. McNagny KM, Pettersson I, Rossi F, Flamme I, Shevchenko A, Mann M, Graf T: Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J Cell Biol 1997;138:1395-1407.
28. Heukamp LC, Fischer HP, Schirmacher P, Chen X, Breuhahn K, Nicolay C, Buttner R, Gutgemann I: Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions. Histopathology 2006;49:242-247.
29. Herbert JM, Stekel D, Sanderson S, Heath VL, Bicknell R: A novel method of differential gene expression analysis using multiple cDNA libraries applied to the identification of tumour endothelial genes. BMC Genomics 2008; 9: 153.
30. Ran S, Downes A, Thorpe PE: Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer research 2002;62:6132-6140.
31. Rybak JN, Roesli C, Kaspar M, Villa A, Neri D: The extra-domain a of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res 2007;67:10948-10957.
32. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW: Genes expressed in human tumor endothelium. Science 2000;289: 1197-1202.
33. Schopperle WM, Kershaw DB, DeWolf WC: Human embryonal carcinoma tumor antigen, GP200/GCTM-2, is podocalyxin. Biochem Biophys Res Commun 2003;300:285-290.
34. Dekan G, Gabel C, Farquhar MG: Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glomerular filtration slits. Proc Natl Acad Sci USA 1991;88:5398-5402.
35. Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM: Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 2001;194:13-27.
36. Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD: Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: Parallels to CD34. J Exp Med 1998;187:1965-1975.
37. Larrucea S, Butta N, Rodriguez RB, Alonso-Martin S, Arias-Salgado EG, Ayuso MS, Parrilla R: Podocalyxin enhances the adherence of cells to platelets. Cell Mol Life Sci 2007;64:2965-2974.
38. Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD: Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res 2004;64:5068-5073.
39. Takeda T, Go WY, Orlando RA, Farquhar MG: Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biology Cell 2000;11:3219-3232.
40. Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G: Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res 2007;67:6183-6191.
41. Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS: Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet 2006;15:735-741.
42. Kelley TW, Huntsman D, McNagny KM, Roskelley CD, Hsi ED: Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol 2005;124:134-142.